1. |
Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis[J]. Ophthalmology, 2014, 121(12): 2387-2392. DOI: 10.1016/j.ophtha.2014.07.007.
|
2. |
Oahalou A, Schellekens PAWJF, De Groot-Mijnes JD, et al. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause[J]. Retina, 2014, 34(1): 108-114. DOI: 10.1097/IAE.0b013e31828e6985.
|
3. |
Bansal R, Gupta A, Gupta V, et al. Safety and outcome of microincision vitreous surgery in uveitis[J]. Ocul Immunol Inflamm, 2017, 25(6): 775-784. DOI: 10.3109/09273948.2016.1165259.
|
4. |
Androudi S, Praidou A, Symeonidis C, et al. Safety and efficacy of small incision, sutureless pars plana vitrectomy for patients with posterior segment complications secondary to uveitis[J/OL]. Acta Ophthalmol, 2012(7): 409-410[2012-07-27]. https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1755-3768.2011.02258.x. DOI:10.1111/j.1755-3768.2011.02258.x.
|
5. |
Carroll DM, Franklin RM. Vitreous biopsy in uveitis of unknown cause[J]. Retina, 1981, 1(3): 245-251. DOI: 10.1097/00006982-198101030-00022.
|
6. |
Okhravi N, Adamson P, Carroll N, et al. PCR-based evidence of bacterial involvement in eyes with suspected intraocular infection[J]. Invest Ophthalmol Vis Sci, 2000, 41(11): 3474-3479.
|
7. |
Jiang T, Zhao Z, Chang Q. Evaluation of cytologic specimens obtained during experimental vitreous biopsy using B-cell lymphoma line[J]. Eur J Ophthalmol, 2014, 24(6): 911-917. DOI: 10.5301/ejo.5000488.
|
8. |
Sato T, Kinoshita R, Taguchi M, et al. Assessment of diagnostic and therapeutic vitrectomy for vitreous opacity associated with uveitis with various etiologies[J/OL]. Medicine (Baltimore), 2018, 97(2): 9491[2018-01-12]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943856/. DOI:10.1097/MD.0000000000009491.
|
9. |
Callaway NF, Gonzalez MA, Yonekawa Y, et al. Outcomes of pars plana vitrectomy for macular hole in patients with uveitis[J]. Retina, 2018, 38(Suppl 1): S41-48. DOI: 10.1097/IAE.0000000000001942.
|
10. |
Rao P, Todorich B, Yonekawa Y, et al. Surgical outcomes of epiretinal membranes in patients with a history of well-controlled preoperative uveitis[J]. Ophthalmol Retina, 2018, 2(3): 192-196. DOI: 10.1016/j.oret.2017.07.002.
|
11. |
Branson SV, McClafferty BR, Kurup SK. Vitrectomy for epiretinal membranes and macular holes in uveitis patients[J]. J Ocul Pharmacol Ther, 2017, 33(4): 298-303. DOI: 10.1089/jop.2016.0142.
|
12. |
Becker M, Davis J. Vitrectomy in the treatment of uveitis[J]. Am J Ophthalmol, 2005, 140(6): 1096-1105. DOI: 10.1016/j.ajo.2005.07.017.
|
13. |
Trittibach P, Koerner F, Sarra GM, et al. Vitrectomy for juvenile uveitis: prognostic factors for the long-term functional outcome[J]. Eye (Lond), 2006, 20(2): 184-190. DOI: 10.1038/sj.eye.6701845.
|
14. |
Henry CR, Becker MD, Yang Y, et al. Pars plana vitrectomy for the treatment of uveitis[J]. Am J Ophthalmol, 2018, 190: 142-149. DOI: 10.1016/j.ajo.2018.03.031.
|
15. |
Quinones K, Choi JY, Yilmaz T, et al. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study[J]. Ocul Immunol Inflamm, 2010, 18(5): 411-417. DOI: 10.3109/09273948.2010.501132.
|